Literature DB >> 33080154

Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity.

Solomon P le Roux1, Caryn Upton1, Naadira Vanker1, Kelly E Dooley2, Andreas H Diacon3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33080154      PMCID： PMC7924570          DOI： 10.1164/rccm.202007-2740LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture.

Authors:  D M O'Sullivan; T D McHugh; S H Gillespie
Journal:  J Med Microbiol       Date:  2010-08-19       Impact factor: 2.472

2.  Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.

Authors:  Sven O Friedrich; Andrea Rachow; Elmar Saathoff; Kasha Singh; Chacha D Mangu; Rodney Dawson; Patrick Pj Phillips; Amour Venter; Anna Bateson; Catharina C Boehme; Norbert Heinrich; Robert D Hunt; Martin J Boeree; Alimuddin Zumla; Timothy D McHugh; Stephen H Gillespie; Andreas H Diacon; Michael Hoelscher
Journal:  Lancet Respir Med       Date:  2013-07-01       Impact factor: 30.700

3.  In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.

Authors:  Dalin Rifat; Victoria L Campodónico; Jing Tao; James A Miller; Alpaslan Alp; Yufeng Yao; Petros C Karakousis
Journal:  Future Microbiol       Date:  2017-03-27       Impact factor: 3.165

4.  Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.

Authors:  Robin J Svensson; Wilber Sabiiti; Gibson S Kibiki; Nyanda E Ntinginya; Nilesh Bhatt; Geraint Davies; Stephen H Gillespie; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

5.  Evaluation of a Urine-Based Rapid Molecular Diagnostic Test with Potential to Be Used at Point-of-Care for Pulmonary Tuberculosis: Cape Town Cohort.

Authors:  Krutarth Patel; Matilde Nagel; Maria Wesolowski; Stefan Dees; Eric Rivera-Milla; Christof Geldmacher; Keertan Dheda; Michael Hoelscher; Ines Labugger
Journal:  J Mol Diagn       Date:  2017-12-18       Impact factor: 5.568

Review 6.  The fitness costs of antibiotic resistance mutations.

Authors:  Anita H Melnyk; Alex Wong; Rees Kassen
Journal:  Evol Appl       Date:  2014-08-27       Impact factor: 5.183

7.  Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.

Authors:  Nicholas D Walter; Camille M Moore; Xavier A Kayigire; Christian Dide-Agossou; William Worodria; Laurence Huang; Charles K Everett; Gary S Schoolnik; Payam Nahid; J Lucian Davis
Journal:  BMC Infect Dis       Date:  2018-07-03       Impact factor: 3.090

8.  Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.

Authors:  Masanori Kawasaki; Carmenchu Echiverri; Lawrence Raymond; Elizabeth Cadena; Evelyn Reside; Maria Tarcela Gler; Tetsuya Oda; Ryuta Ito; Ryo Higashiyama; Kiyonori Katsuragi; Yongge Liu
Journal:  PLoS Med       Date:  2019-04-12       Impact factor: 11.069

9.  Machine learning and structural analysis of Mycobacterium tuberculosis pan-genome identifies genetic signatures of antibiotic resistance.

Authors:  Erol S Kavvas; Edward Catoiu; Nathan Mih; James T Yurkovich; Yara Seif; Nicholas Dillon; David Heckmann; Amitesh Anand; Laurence Yang; Victor Nizet; Jonathan M Monk; Bernhard O Palsson
Journal:  Nat Commun       Date:  2018-10-17       Impact factor: 14.919

10.  Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial.

Authors:  Kelly E Dooley; Sachiko Miyahara; Florian von Groote-Bidlingmaier; Xin Sun; Richard Hafner; Susan L Rosenkranz; Elisa H Ignatius; Eric L Nuermberger; Laura Moran; Kathleen Donahue; Susan Swindells; Naadira Vanker; Andreas H Diacon
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405
  10 in total
  1 in total

1.  A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.

Authors:  Kamunkhwala Gausi; Elisa H Ignatius; Xin Sun; Soyeon Kim; Laura Moran; Lubbe Wiesner; Florian von Groote-Bidlingmaier; Richard Hafner; Kathleen Donahue; Naadira Vanker; Susan L Rosenkranz; Susan Swindells; Andreas H Diacon; Eric L Nuermberger; Kelly E Dooley; Paolo Denti
Journal:  Am J Respir Crit Care Med       Date:  2021-12-01       Impact factor: 21.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.